We showed that several type I MAGE, particularly MAGE-A3, C1, and C2, are commonly expressed in multiple myeloma (MM), a cancer of plasma cells, and are associated with proliferation and resistance to apoptosis [8, 9]. The gene discussed is MAGEA3; the disease is plasma cell myeloma.